New startup ideas · Health and bio · Healthcare and bio
startup idea
Echofield
Any ultrasound probe, any small clinic, one shared interpretation and overread network.
Echofield sells small clinics worldwide a subscription that turns an existing or Echofield-supplied low-cost probe into a guided scanner: the software coaches an untrained operator through a standard sweep, produces a structured report from a multi-vendor ultrasound model, and routes anything uncertain to a credentialed reader inside the network.
- Software subscription
- Small business
- $10-100B market
- Network effects, winner takes most
- Global from day one
3/5
venture judge
11
similar startups, last 2 years (47 all-time)
97%
of 4 nearest real companies still alive
yes
8 matching federal grants and programs
Direction supported by government programs and grants
Test it before you build it
$2,600 · 6 weeks · 20 prospects
For about $2,600 and six weeks, prove that US clinics with an idle ultrasound will prepay $250 to reserve a tele-guided scanning and credentialed overread service run entirely by hand.
1Focus group: who and where
Owner-physician or practice manager of an independent US family practice, direct primary care, or OB/GYN clinic with 1-5 providers that owns a cart ultrasound used less than weekly because it cannot retain or afford a sonographer
where to find 20 · The DPC Alliance member directory and the DPC Summit attendee community; MGMA's member forum for practice managers; LinkedIn Sales Navigator filtered on 'practice owner' plus 'family medicine' or 'obstetrics' at US companies with 2-10 employees
2Sell first, build later
A tele-guided scanning service for your existing machine: a remote credentialed sonographer guides your MA through booked sessions and a US-licensed radiologist returns a signed report within 24 hours, starting October 12, up to 20 studies per month
the ask · $495 per month per site, 3-month pilot, first month invoiced up front
a real yes · A real yes is a paid $250 reservation or a paid first month with a signed pilot and a calendar-blocked weekly session. Not a yes: 'we would definitely use this', a free trial request, or interest from a clinic that cannot name which staff member would hold the probe
3Small experiments
The first one attacks the riskiest assumption; each ends with a number that says whether to run the next.
1. Idle probe discovery calls
$200 · 14 days
Book 15 twenty-minute calls with clinic owners recruited through DPC Alliance contacts and Sales Navigator. Script: what ultrasound do you own, when was it last used, what did you refer out last month that you could have scanned in-house, what does the referral cost your patient. Founder runs all calls.
keep going if · 10 of 15 own a working machine used less than weekly and name at least one scan type they refer out every week
2. Priced landing page with reservation
$600 · 21 days
Publish a one-page site: guided scans by a remote credentialed sonographer plus radiologist overreads, $495 per month per site including 20 overreads, first cohort starts October 12, reserve with a $250 refundable deposit via Stripe Payment Link. Send it to every call prospect and spend $500 on Google Ads against 'ultrasound overread service' and 'teleultrasound for clinics'.
keep going if · 6 of 20 contacted clinics click through to the Stripe page and 4 pay the $250 deposit
3. Wizard-of-Oz tele-guided scans
$1,300 · 28 days
For 3 clinics from the calls, run 10 total live sessions: an hourly-contracted registered sonographer coaches the clinic's medical assistant through a limited scan (bladder, aorta, OB dating) over Zoom, and a contracted US teleradiologist reads each study for a per-read fee. Everything is licensed humans, so no device clearance is needed for the test.
keep going if · 8 of 10 sessions produce a report the physician accepts into the chart, and all 3 clinics request a recurring weekly slot
4. Prepaid pilot close
$100 · 14 days
Offer the 3 concierge clinics and every deposit holder a 3-month pilot at $495 per month, first month invoiced up front, with a signed one-page agreement naming the operator who will scan and the weekly session slot. Founder closes each by phone.
keep going if · 3 clinics pay the first $495 invoice with a named operator and a calendar-blocked weekly session
4Collect a deposit up front
Tesla took $1,000 refundable reservations for the Model 3 and $100 for the Cybertruck before building either: the deposit is the measurement, not the revenue.
$250
per prospect, refundable
how · A $250 refundable reservation via a Stripe Payment Link, paid by the practice owner from the landing page or on the call; the receipt email restates the price lock and cohort date set up: Stripe Payment Links ↗
what it reserves · One of 10 first-cohort slots, the $495 per month price locked for 12 months, and choice of weekly session time
refund · Refunded in full anytime before the first scheduled session, no questions asked
target · 6 deposits from 20 contacted clinics within 30 days
Go: build it if
6 reservations paid, 8 of 10 concierge scans accepted into the chart, and 3 pilots paid at $495 with named operators
Kill: stop if
Fewer than 3 deposits from 20 clinics, or physicians reject more than half the concierge reports, or no contracted radiologist will read MA-acquired studies at a workable per-read fee
Would you run this test?
One tap. The yes-share feeds the Demand pillar of this idea's score; nobody sees who answered.
Budgets are out-of-pocket estimates for a team of one to three, US market. Size the deposit to the deal, and check the terms before taking money in a regulated line.
Scorecard
One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.
72
Idea Score, 0-100 · raw 43.8 x 1.64
Crowded
competition: more crowded than 75% of ideas · headwind x0.63
+4.7
government priorities, secondary (139 matching grants)
Trend
66
Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.
- Entrants 2025-26 vs 2023-24 (similar companies)61
- Rounds announced 2025+ in the sector55
- Sector direction (live batch)100
- 2026 trend analyst50
Demand
60
Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.
- YC asks for it (current RFS: idea / sector)30
- Someone already pays (similar companies, recent / all-time)100
- Operator judge: real pain50
100x potential
61
Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.
- Venture judge50
- Market size axis67
- Moat axis100
- Neighbours still alive24
- Technologist judge75
Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were ultrasound, probe, clinic, shared, interpretation, sells, clinics, worldwide.
The idea in full
- What
- Echofield sells small clinics worldwide a subscription that turns an existing or Echofield-supplied low-cost probe into a guided scanner: the software coaches an untrained operator through a standard sweep, produces a structured report from a multi-vendor ultrasound model, and routes anything uncertain to a credentialed reader inside the network. Clinics sign up and provision themselves online at a flat monthly price per site. Echofield manufactures a cheap capture dongle so legacy cart machines can join, and carries the device clearances in each market it opens.
- Why now
- The current cohorts contain three separate attempts at cheap accessible screening, Lumius (yc X26) on 3D ultrasound, Adialante (yc X26) on cancer screening and Carevision Inc. (500global 500G MENA 11) on 60-second cardiometabolic screening, all of them building their own device or their own clinic; meanwhile the CDC-GHC grant Strengthening Ghana Health Service laboratory services, diagnostic networks, and systems, closing 2026-10-16, shows the buyer for a network layer that spans existing equipment.
- Wedge: first customer and entry point
- Independent obstetric and general practice clinics in two or three high-volume markets that already own an idle cart ultrasound and cannot retain a sonographer.
- Path to 100x
- Small-clinic imaging and point-of-care diagnostics is a $10-100B global spend, and it is fragmented enough that no incumbent can sell to it directly. Every new clinic adds scans that improve the multi-vendor model and adds readers that shorten turnaround for everyone else, so quality and price both improve with density and the largest network is the cheapest one to join.
- Ceiling
- Country-by-country device clearance and reader credentialing could slow expansion enough that the network never reaches the density its economics require.
- Closest real companies, as the generator saw them
- Lumius builds a new device, Carevision Inc. builds a screening station, Radley builds an AI-native radiology practice and Lattice Health governs deployed imaging AI. Echofield is vendor-neutral connective tissue: it monetizes clinics that keep the hardware they already have and share reading capacity with each other.
- Main risk
- Clearance and liability for autonomous interpretation vary by country, and the reader network may not scale fast enough to cover the scans the software escalates.
Five judges
Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).
Venture investor
3/5
Reader overread capacity is human labor that scales linearly, and country-by-country clearance slows the density the network economics require.
Bootstrapper
1/5
Carrying device clearances country by country plus manufacturing a capture dongle is exactly the regulatory-plus-hardware path this lens avoids.
Operator
3/5
Idle cart ultrasound plus no sonographer is real pain, but flat monthly per-site pricing to fragmented small clinics is thin money per buyer.
Technologist
4/5
Operator-guidance plus a multi-vendor model, a capture dongle for legacy carts and per-market clearances is years of work, not a weekend integration.
Risk
2/5
Autonomous interpretation needs device clearance and reader credentialing country by country, with liability exposure the card admits varies by market.
trends
3/5
The CDC Ghana diagnostics grant closing 2026-10-16 earns the secondary government point, but guided ultrasound overreads existed well before 2025.
Similar startups in the directory
Companies whose pitch matches most of the idea's terms (ultrasound, probe, clinic, shared, interpretation, sells, clinics, worldwide): 47 all-time, 11 from the last two years. Same matching as Idea Check.
Fast, smart, accessible 3D ultrasound that anyone can use
Datavant is a provider of a healthcare data solutions to help institutions share, protect, and match health data.
AI Diagnosis of Heart Disease
Software for medical laboratories and clinics
Platform for breakthrough mental health research and treatment
Building the future of women's health imaging diagnostics with AI-driven interpretation for gynecology.
Transforming Drug Discovery with models that reflect human physiology.
Head Diagnostics offers AI-driven digital tools for cognitive and neurological assessment.
Vibecode + deploy HIPAA-compliant internal tools, no eng team needed
The first AI-native radiology practice
Helping Healthcare Providers Speak Any Language
AI agents on real phones, growing brands across every platform.
The generator's reference companies
Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.
Public money in this direction
US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.
8
grants and programs matching the idea
1135
startup-relevant grants in Healthcare and bio
$598M
awarded in the sector, tracked
130
opportunities open now in the sector
- A Longitudinal Multimodal Risk Prediction Platform for Personalized Breast Cancer Screeningawardhigh relevance
NIH / NCI · SBIR phase I · $400K · posted 2026-08-03
- SBIR Phase II: AI-Driven Visualization of Rehabilitation Documentation to Support Decision-Making Across Care Settingsawardhigh relevance
National Science Foundation · SBIR Phase II · $1M · posted 2026-07-20
- Enhancing Antifungal Efficacy: Leveraging PCA Pathway Inhibitors as Antimicrobial Adjuvantsawardhigh relevance
NIH / NIAID · SBIR phase II · $1M · posted 2026-07-14
- Development of an automated image enhancement system to improve point-of-care ultrasound imaging for out-of-hospital settingsawardhigh relevance
NIH / NIMHD · SBIR phase I · $337K · posted 2025-09-17
- Scaling Lymphoma Diagnosis: A Cost-Effective Gene Expression Assay for Broad Implementationawardhigh relevance
NIH / NCI · SBIR phase II · $2M · posted 2025-09-17
NIH / NIMH · STTR phase II · $450K · posted 2025-09-12
NIH / NCI · SBIR phase II · $407K · posted 2025-09-08
- Development of Deep Learning Tools for Widely-Available, Inexpensive Diagnosis of Coronary Microvascular and Vasomotor Dysfunctionawardhigh relevance
NIH / NHLBI · SBIR phase II · $1M · posted 2025-09-05
Market signal
What the radar sees in Healthcare and bio: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.
Healthcare and bio · 135 → 119 → 224 → 170 → 92 new companies 2022 → 2026 · 92% aliveYC S26: 14 in this cluster, 6% of the batch (was 4% in X26) (F26 is still forming: 24 listed)Since February, of 444 YC companies here: 4 acquired, 5 shut down, 38 rewrote their pitch
Design attributes
The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.
- Buyer
- Small business
- Business model
- Software subscription
- Path to 100x
- Network effects, winner takes most
- Market size
- $10-100B market
- Capital intensity
- Capital-heavy (hardware, bio, infra)
- Speed to revenue
- Revenue in 1-3 years
- Technical depth
- Deep tech: ML, hardware, bio
- Go-to-market
- Self-serve
- Moat
- Network effects
- Geography
- Global from day one
- Regulation
- Some regulation
- Vibe
- Boring business
Listed under
An idea sits in its own sector and in any sector its text clearly touches.
More ideas like this
Health and bio · Healthcare and bio
Bylaw Health
The licensed medical group behind your API call, in fifty states.
Bylaw Health holds the professional corporations, state clinician licenses, supervision agreements and payer enrollments in every US state, and exposes them as endpoints: create a clinician, attach a supervising physician, enroll a location with a payer, submit an encounter under a compliant entity.
Health and bio · Healthcare and bio
Bayworks
Licensed GMP manufacturing bays for personalized therapies, sold as bookable capacity.
Bayworks builds standardized, FDA-registered cleanroom modules inside hospital systems and partner CDMO sites, then runs a marketplace where drug sponsors book manufacturing slots by the batch instead of signing multi-year suite reservations.
Health and bio · Healthcare and bio
Assaygrid
Predicts which lab runs will fail before reagents are consumed, across every instrument vendor.
Assaygrid connects to the instrument fleet of pharma, biotech and industrial R&D organizations, learns from run telemetry, reagent lots, operator steps and outcomes, and flags runs likely to fail plus the parameter change that fixes them.
Health and bio · Healthcare and bio
Overturn
Agents that fight payer denials for health systems, then sell what wins.
Overturn deploys an agent workforce inside a health system's revenue cycle that reads each denial, pulls the governing payer medical policy, assembles the clinical record and files the appeal, working through existing EHR and clearinghouse integrations rather than new infrastructure.
Health and bio · Healthcare and bio
Labmesh
Agents that design, order and run preclinical experiments across a global lab network.
Labmesh gives a biotech or pharma scientist an agent that takes a hypothesis, decomposes it into assays, prices and routes each assay to a contract lab on its network, tracks samples, and returns structured results with the raw instrument files.
Health and bio · Healthcare and bio
ChartRail
The consented medical-records rail every AI clinic runs on.
An API that lets AI-native care companies pull a patient's complete medical record with verifiable consent, by operating as a qualified participant in the national health information exchange framework and as a registered clearinghouse.
Fictional company written 2026-08-22 from MarkosWeb data; the companies, grants and numbers around it are real and tracked. Treat the idea as a research prompt, not a plan.